Retinal Disorders Drugs Market Report

Global and Region Retinal Disorders Drugs Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：144
  • REPORT CODE：GMM948948
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Retinal Disorders Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Retinal Disorders Drugsmarket, defines the market attractiveness level of Retinal Disorders Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Retinal Disorders Drugs industry, describes the types of Retinal Disorders Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Retinal Disorders Drugs market and the development prospects and opportunities of Retinal Disorders Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Retinal Disorders Drugs market in Chapter 13.

    By Player:

    • Roche

    • Bausch & Lomb

    • Bristol-Myers Squibb

    • AbbVie

    • Janssen Biotech

    • Swedish Orphan Biovitrum

    • UCBCares

    • OCULAR THERAPEUTIX

    • Genzyme

    • Alimera Sciences

    • ALLERGAN

    • Genentech

    By Type:

    • Age Related Macular Degeneration

    • Diabetic Retinopathy

    • Ocular Inflammatory Disease (Uveitis)

    • Macular Hole

    By End-User:

    • Hospitals

    • Clinics

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Retinal Disorders Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Retinal Disorders Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Retinal Disorders Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Retinal Disorders Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Retinal Disorders Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Retinal Disorders Drugs Consumption (2017-2022)

    • 7.2 United States Retinal Disorders Drugs Consumption (2017-2022)

    • 7.3 Europe Retinal Disorders Drugs Consumption (2017-2022)

    • 7.4 China Retinal Disorders Drugs Consumption (2017-2022)

    • 7.5 Japan Retinal Disorders Drugs Consumption (2017-2022)

    • 7.6 India Retinal Disorders Drugs Consumption (2017-2022)

    • 7.7 South Korea Retinal Disorders Drugs Consumption (2017-2022)

    8 Region and Country-wise Retinal Disorders Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Retinal Disorders Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Retinal Disorders Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Retinal Disorders Drugs Consumption Forecast (2022-2028)

    • 8.4 China Retinal Disorders Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Retinal Disorders Drugs Consumption Forecast (2022-2028)

    • 8.6 India Retinal Disorders Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Retinal Disorders Drugs Consumption Forecast (2022-2028)

    9 Global Retinal Disorders Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Retinal Disorders Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Age Related Macular Degeneration Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Diabetic Retinopathy Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Ocular Inflammatory Disease (Uveitis) Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Macular Hole Consumption and Growth Rate (2017-2022)

    • 9.2 Global Retinal Disorders Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Retinal Disorders Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Retinal Disorders Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Age Related Macular Degeneration Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Diabetic Retinopathy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Ocular Inflammatory Disease (Uveitis) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Macular Hole Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Retinal Disorders Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Retinal Disorders Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Retinal Disorders Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Retinal Disorders Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Retinal Disorders Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Retinal Disorders Drugs Market Competitive Analysis

    • 14.1 Roche

      • 14.1.1 Roche Company Details

      • 14.1.2 Roche Retinal Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Roche Retinal Disorders Drugs Product and Service

    • 14.2 Bausch & Lomb

      • 14.2.1 Bausch & Lomb Company Details

      • 14.2.2 Bausch & Lomb Retinal Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Bausch & Lomb Retinal Disorders Drugs Product and Service

    • 14.3 Bristol-Myers Squibb

      • 14.3.1 Bristol-Myers Squibb Company Details

      • 14.3.2 Bristol-Myers Squibb Retinal Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Bristol-Myers Squibb Retinal Disorders Drugs Product and Service

    • 14.4 AbbVie

      • 14.4.1 AbbVie Company Details

      • 14.4.2 AbbVie Retinal Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 AbbVie Retinal Disorders Drugs Product and Service

    • 14.5 Janssen Biotech

      • 14.5.1 Janssen Biotech Company Details

      • 14.5.2 Janssen Biotech Retinal Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Janssen Biotech Retinal Disorders Drugs Product and Service

    • 14.6 Swedish Orphan Biovitrum

      • 14.6.1 Swedish Orphan Biovitrum Company Details

      • 14.6.2 Swedish Orphan Biovitrum Retinal Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Swedish Orphan Biovitrum Retinal Disorders Drugs Product and Service

    • 14.7 UCBCares

      • 14.7.1 UCBCares Company Details

      • 14.7.2 UCBCares Retinal Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 UCBCares Retinal Disorders Drugs Product and Service

    • 14.8 OCULAR THERAPEUTIX

      • 14.8.1 OCULAR THERAPEUTIX Company Details

      • 14.8.2 OCULAR THERAPEUTIX Retinal Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 OCULAR THERAPEUTIX Retinal Disorders Drugs Product and Service

    • 14.9 Genzyme

      • 14.9.1 Genzyme Company Details

      • 14.9.2 Genzyme Retinal Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Genzyme Retinal Disorders Drugs Product and Service

    • 14.10 Alimera Sciences

      • 14.10.1 Alimera Sciences Company Details

      • 14.10.2 Alimera Sciences Retinal Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Alimera Sciences Retinal Disorders Drugs Product and Service

    • 14.11 ALLERGAN

      • 14.11.1 ALLERGAN Company Details

      • 14.11.2 ALLERGAN Retinal Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 ALLERGAN Retinal Disorders Drugs Product and Service

    • 14.12 Genentech

      • 14.12.1 Genentech Company Details

      • 14.12.2 Genentech Retinal Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Genentech Retinal Disorders Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Retinal Disorders Drugs

    • Figure Retinal Disorders Drugs Picture

    • Table Global Retinal Disorders Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Retinal Disorders Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Retinal Disorders Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Retinal Disorders Drugs Consumption by Country (2017-2022)

    • Figure United States Retinal Disorders Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Retinal Disorders Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Retinal Disorders Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Retinal Disorders Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Retinal Disorders Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Retinal Disorders Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Retinal Disorders Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Retinal Disorders Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Retinal Disorders Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Retinal Disorders Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Retinal Disorders Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Retinal Disorders Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Retinal Disorders Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Age Related Macular Degeneration Consumption and Growth Rate (2017-2022)

    • Figure Global Diabetic Retinopathy Consumption and Growth Rate (2017-2022)

    • Figure Global Ocular Inflammatory Disease (Uveitis) Consumption and Growth Rate (2017-2022)

    • Figure Global Macular Hole Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Age Related Macular Degeneration Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diabetic Retinopathy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ocular Inflammatory Disease (Uveitis) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Macular Hole Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Retinal Disorders Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Retinal Disorders Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Retinal Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Retinal Disorders Drugs Product and Service

    • Table Bausch & Lomb (Foundation Year, Company Profile and etc.)

    • Table Bausch & Lomb Retinal Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bausch & Lomb Retinal Disorders Drugs Product and Service

    • Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Retinal Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Retinal Disorders Drugs Product and Service

    • Table AbbVie (Foundation Year, Company Profile and etc.)

    • Table AbbVie Retinal Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Retinal Disorders Drugs Product and Service

    • Table Janssen Biotech (Foundation Year, Company Profile and etc.)

    • Table Janssen Biotech Retinal Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Janssen Biotech Retinal Disorders Drugs Product and Service

    • Table Swedish Orphan Biovitrum (Foundation Year, Company Profile and etc.)

    • Table Swedish Orphan Biovitrum Retinal Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Swedish Orphan Biovitrum Retinal Disorders Drugs Product and Service

    • Table UCBCares (Foundation Year, Company Profile and etc.)

    • Table UCBCares Retinal Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table UCBCares Retinal Disorders Drugs Product and Service

    • Table OCULAR THERAPEUTIX (Foundation Year, Company Profile and etc.)

    • Table OCULAR THERAPEUTIX Retinal Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table OCULAR THERAPEUTIX Retinal Disorders Drugs Product and Service

    • Table Genzyme (Foundation Year, Company Profile and etc.)

    • Table Genzyme Retinal Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genzyme Retinal Disorders Drugs Product and Service

    • Table Alimera Sciences (Foundation Year, Company Profile and etc.)

    • Table Alimera Sciences Retinal Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alimera Sciences Retinal Disorders Drugs Product and Service

    • Table ALLERGAN (Foundation Year, Company Profile and etc.)

    • Table ALLERGAN Retinal Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table ALLERGAN Retinal Disorders Drugs Product and Service

    • Table Genentech (Foundation Year, Company Profile and etc.)

    • Table Genentech Retinal Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genentech Retinal Disorders Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US